| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |